MacroBID® now Pharmac funded on the PSO
Updated: July 1, 2022 PHARMAC has now implemented widened funded access to the first line UTI treatment MacroBID® modified release...
NEWS
- Nov 27, 2021
Medsafe Approves Trientine Tetrahydrochloride (Cuprior) for the Treatment Of Wilson's Disease
Te Arai BioFarma are happy to announce that Medsafe has approved an innovative new treatment for Wilson's Disease, trientine...
- Oct 29, 2020
PHARMAC funds new medicine MacroBID®
PHARMAC today announced their decision to fund MacroBID® modified release nitrofurantoin capsules. MacroBID® is a modified release...